$MNKD
MANNKIND CORP

2020 Form 10-K Financial Statement

#000156459021008440 Filed on February 25, 2021

View on sec.gov

Income Statement

Concept 2020 2019 Q4 2019
Revenue $65.14M $15.99M $63.04M
YoY Change 3.34% -0.24% 126.28%
Cost Of Revenue $15.08M $7.000M $20.08M
YoY Change -24.87% 14.75% 3.54%
Gross Profit $50.06M $9.000M $42.96M
YoY Change 16.53% -10.0% 407.38%
Gross Profit Margin 76.85% 56.27% 68.15%
Selling, General & Admin $59.04M $15.70M $74.67M
YoY Change -20.93% -12.78% -6.33%
% of Gross Profit 117.94% 174.44% 173.81%
Research & Development $6.248M $2.000M $6.900M
YoY Change -9.45% 81.82% -21.03%
% of Gross Profit 12.48% 22.22% 16.06%
Depreciation & Amortization $1.800M $560.0K $1.600M
YoY Change 12.5% 51.35% -5.88%
% of Gross Profit 3.6% 6.22% 3.72%
Operating Expenses $65.29M $17.70M $81.57M
YoY Change -19.96% -7.33% -7.78%
Operating Profit -$47.91M -$8.700M -$44.60M
YoY Change 7.44% -4.4% -41.78%
Interest Expense -$17.30M -$4.700M -$8.000M
YoY Change 116.25% 4600.0% 81.82%
% of Operating Profit
Other Income/Expense, Net $0.00 -$800.0K -$7.306M
YoY Change -100.0% 60.0% -27.95%
Pretax Income -$57.46M -$14.30M -$51.90M
YoY Change 10.7% 45.92% -40.16%
Income Tax -$218.0K $0.00 $0.00
% Of Pretax Income
Net Earnings -$57.24M -$14.26M -$51.90M
YoY Change 10.28% 46.33% -40.32%
Net Earnings / Revenue -87.87% -89.18% -82.34%
Basic Earnings Per Share -$0.26
Diluted Earnings Per Share -$257.0K -$69.08K -$265.3K
COMMON SHARES
Basic Shares Outstanding 222.6M
Diluted Shares Outstanding 222.6M

Balance Sheet

Concept 2020 2019 Q4 2019
SHORT-TERM ASSETS
Cash & Short-Term Investments $67.00M $49.90M $49.90M
YoY Change 34.27% -29.92% -29.92%
Cash & Equivalents $67.00M $29.91M $29.90M
Short-Term Investments $0.00 $20.00M $20.00M
Other Short-Term Assets $3.300M $3.200M $3.200M
YoY Change 3.13% 3.23% 3.23%
Inventory $5.000M $4.155M $4.200M
Prepaid Expenses
Receivables $8.100M $3.513M $6.900M
Other Receivables -$3.900M $0.00 -$3.400M
Total Short-Term Assets $79.50M $60.76M $60.80M
YoY Change 30.76% -25.77% -25.76%
LONG-TERM ASSETS
Property, Plant & Equipment $25.90M $26.78M $30.00M
YoY Change -13.67% 4.59% 17.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.300M $6.190M $3.000M
YoY Change 10.0% 2385.94% 1400.0%
Total Long-Term Assets $29.10M $32.97M $32.90M
YoY Change -11.55% 27.53% 27.52%
TOTAL ASSETS
Total Short-Term Assets $79.50M $60.76M $60.80M
Total Long-Term Assets $29.10M $32.97M $32.90M
Total Assets $108.6M $93.73M $93.70M
YoY Change 15.9% -12.98% -13.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.600M $4.789M $4.800M
YoY Change 16.67% -10.97% -11.11%
Accrued Expenses $17.50M $15.90M $15.50M
YoY Change 12.9% 5.87% 10.71%
Deferred Revenue $32.50M
YoY Change -11.88%
Short-Term Debt $0.00 $5.000M $5.000M
YoY Change -100.0% -55.75% -55.75%
Long-Term Debt Due $4.100M $5.028M
YoY Change
Total Short-Term Liabilities $73.70M $65.62M $65.60M
YoY Change 12.35% -12.79% -12.77%
LONG-TERM LIABILITIES
Long-Term Debt $118.2M $113.9M $113.9M
YoY Change 3.78% 24.86% 24.89%
Other Long-Term Liabilities $97.10M $104.8M $104.8M
YoY Change -7.35% -9.97% -9.97%
Total Long-Term Liabilities $215.3M $113.9M $218.7M
YoY Change -1.55% -45.15% 5.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $73.70M $65.62M $65.60M
Total Long-Term Liabilities $215.3M $113.9M $218.7M
Total Liabilities $289.0M $284.3M $284.3M
YoY Change 1.65% 0.52% 0.53%
SHAREHOLDERS EQUITY
Retained Earnings -$2.992B
YoY Change 1.77%
Common Stock $2.801B
YoY Change 1.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$180.4M -$190.5M -$190.5M
YoY Change
Total Liabilities & Shareholders Equity $108.6M $93.73M $93.70M
YoY Change 15.9% -12.98% -13.0%

Cashflow Statement

Concept 2020 2019 Q4 2019
OPERATING ACTIVITIES
Net Income -$57.24M -$14.26M -$51.90M
YoY Change 10.28% 46.33% -40.32%
Depreciation, Depletion And Amortization $1.800M $560.0K $1.600M
YoY Change 12.5% 51.35% -5.88%
Cash From Operating Activities -$28.13M -$5.100M -$88.48M
YoY Change -68.21% -120.41% 134.51%
INVESTING ACTIVITIES
Capital Expenditures $801.0K -$110.0K $2.565M
YoY Change -68.77% -68.57% 624.58%
Acquisitions
YoY Change
Other Investing Activities $20.00M -$90.00K -$20.28M
YoY Change -198.62% -181.82% -17000.0%
Cash From Investing Activities $15.22M -$200.0K -$22.84M
YoY Change -166.61% -16.67% 9661.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 49.85M 5.040M 69.86M
YoY Change -28.64% -85.98% 13.98%
NET CHANGE
Cash From Operating Activities -28.13M -5.100M -88.48M
Cash From Investing Activities 15.22M -200.0K -22.84M
Cash From Financing Activities 49.85M 5.040M 69.86M
Net Change In Cash 36.94M -260.0K -41.46M
YoY Change -189.1% -100.43% -277.73%
FREE CASH FLOW
Cash From Operating Activities -$28.13M -$5.100M -$88.48M
Capital Expenditures $801.0K -$110.0K $2.565M
Free Cash Flow -$28.93M -$4.990M -$91.05M
YoY Change -68.23% -119.69% 139.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.9425
CY2020Q4 mnkd Milestone Rights Liabilities Noncurrent
MilestoneRightsLiabilitiesNoncurrent
5926000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
95364000
CY2019Q4 mnkd Accrued Interest Noncurrent
AccruedInterestNoncurrent
2002000
CY2019Q4 mnkd Promissory Notes Noncurrent
PromissoryNotesNoncurrent
70020000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3513000
CY2019Q4 us-gaap Inventory Net
InventoryNet
4155000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2889000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26778000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15084000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4789000
CY2019Q4 us-gaap Assets
Assets
93725000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29906000
CY2019Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
316000
CY2019Q4 us-gaap Short Term Investments
ShortTermInvestments
19978000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0039
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0152
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.9383
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.9305
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0152
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0251
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.9425
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M2D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y5M12D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y7M13D
CY2020 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2019Q4 us-gaap Assets Current
AssetsCurrent
60757000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6190000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15904000
CY2020Q4 mnkd Paycheck Protection Program Loan Current
PaycheckProtectionProgramLoanCurrent
4061000
CY2019Q4 us-gaap Notes Payable Current
NotesPayableCurrent
5028000
CY2020 mnkd Stock Issued During Period Value Stock Options And Restricted Stock Units Net Of Forfeitures
StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures
233000
CY2019 us-gaap Profit Loss
ProfitLoss
-51903000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
6511000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2565000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
32503000
CY2019Q4 mnkd Purchase Obligation Current
PurchaseObligationCurrent
7394000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
65618000
CY2020Q4 mnkd Credit Facility Noncurrent
CreditFacilityNoncurrent
49335000
CY2019Q4 mnkd Credit Facility Noncurrent
CreditFacilityNoncurrent
38851000
CY2020Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
5000000
CY2019Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
5000000
CY2019Q4 mnkd Milestone Rights Liabilities Noncurrent
MilestoneRightsLiabilitiesNoncurrent
7263000
CY2020Q4 mnkd Paycheck Protection Program Loan Noncurrent
PaycheckProtectionProgramLoanNoncurrent
812000
CY2020 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
13233000
CY2020 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
6248000
CY2019 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
6900000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
59040000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
74669000
CY2020 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
1889000
CY2020 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-8006000
CY2019 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
1913000
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
107635000
CY2020 mnkd Interest Expense Incurred On Promissory Notes
InterestExpenseIncurredOnPromissoryNotes
5155000
CY2019 mnkd Interest Expense Incurred On Promissory Notes
InterestExpenseIncurredOnPromissoryNotes
4602000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-218000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-57240000
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
222585000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
195584000
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-19000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-57259000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-51903000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-175082000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
124000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
67163000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30222000
CY2019 mnkd Payment In Kind Interest On Promissory Notes
PaymentInKindInterestOnPromissoryNotes
32822000
CY2020 mnkd Interest Expense On Promissory Notes
InterestExpenseOnPromissoryNotes
5148000
CY2019 mnkd Interest Expense On Promissory Notes
InterestExpenseOnPromissoryNotes
4712000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
6203000
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1889000
CY2020 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-8006000
CY2019 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
1913000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-264000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
705000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-504000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1314000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
558000
CY2019 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
656000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6203000
CY2019 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
4575000
CY2019 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-2000
CY2019 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
60000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
154000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
333000
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-227000
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
549000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
793000
CY2020 us-gaap Profit Loss
ProfitLoss
-57240000
CY2020 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
13233000
CY2020 mnkd Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
1177000
CY2019 mnkd Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
1182000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2149000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
972000
CY2019 mnkd Gain Loss On Warrant Transactions
GainLossOnWarrantTransactions
-868000
CY2020 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
496000
CY2020 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-19000
CY2019 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-107000
CY2019 mnkd Adjustments To Additional Paid In Capital Issuance Of Warrants Pursuant To Credit Facility
AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility
1854000
CY2019 mnkd Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
5900000
CY2019 mnkd Adjustments To Additional Paid In Capital Warrant Modification
AdjustmentsToAdditionalPaidInCapitalWarrantModification
688000
CY2019 mnkd Adjustments To Additional Paid In Capital Repurchased Warrant
AdjustmentsToAdditionalPaidInCapitalRepurchasedWarrant
-253000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-51903000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-190526000
CY2020 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
519000
CY2020 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
684000
CY2020 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
9250000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6511000
CY2020 mnkd Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
11600000
CY2020 mnkd Stock Issued During Period Value Market Price Stock Purchase Plan
StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan
215000
CY2020 mnkd Adjustments To Additional Paid In Capital Issuance Of Warrants Pursuant To Credit Facility
AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility
275000
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-19000
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
3529000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-593000
CY2020 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3346000
CY2019 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2821000
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5910000
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-6717000
CY2020 mnkd Increase Decrease In Recognized Loss On Purchase Commitments
IncreaseDecreaseInRecognizedLossOnPurchaseCommitments
-4751000
CY2019 mnkd Increase Decrease In Recognized Loss On Purchase Commitments
IncreaseDecreaseInRecognizedLossOnPurchaseCommitments
-4395000
CY2020 mnkd Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1312000
CY2019 mnkd Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-995000
CY2019 mnkd Increase Decrease In Accrued Interest On Promissory Notes
IncreaseDecreaseInAccruedInterestOnPromissoryNotes
1545000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28128000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-88483000
CY2020 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
20000000
CY2019 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
24993000
CY2020 us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
3983000
CY2019 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
44971000
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
519000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
801000
CY2019 us-gaap Payments To Acquire Limited Partnership Interests
PaymentsToAcquireLimitedPartnershipInterests
300000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
15216000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22843000
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
11600000
CY2019 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
5900000
CY2020 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
10000000
CY2019 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
40000000
CY2020 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
4873000
CY2020 mnkd Payments Related To Employment Taxes For Share Based Compensation And Proceeds From Exercise Of Stock Options
PaymentsRelatedToEmploymentTaxesForShareBasedCompensationAndProceedsFromExerciseOfStockOptions
-233000
CY2019 mnkd Payments Related To Employment Taxes For Share Based Compensation And Proceeds From Exercise Of Stock Options
PaymentsRelatedToEmploymentTaxesForShareBasedCompensationAndProceedsFromExerciseOfStockOptions
-124000
CY2020 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
215000
CY2019 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
70051000
CY2019 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
9910000
CY2019 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
38264000
CY2019 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
11081000
CY2019 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
6920000
CY2019 mnkd Milestone Payments
MilestonePayments
1643000
CY2019 mnkd Repayment Of Issuance Of Credit Facility
RepaymentOfIssuanceOfCreditFacility
886000
CY2019 us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
433000
CY2019 mnkd Repayments Of Issuance Promissory Notes
RepaymentsOfIssuancePromissoryNotes
33000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
49853000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
69864000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
36941000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-41462000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30222000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
71684000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
3558000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
1757000
CY2020 mnkd Issuance Of Common Stock For Acquisition Of In Process Research And Development
IssuanceOfCommonStockForAcquisitionOfInProcessResearchAndDevelopment
9250000
CY2020 us-gaap Notes Issued1
NotesIssued1
7000000
CY2019 us-gaap Notes Issued1
NotesIssued1
8000000
CY2020 mnkd Payment On Interest Of Promissory Notes Through Issuance Of Common Stock
PaymentOnInterestOfPromissoryNotesThroughIssuanceOfCommonStock
3000000
CY2020 us-gaap Stock Issued1
StockIssued1
5261000
CY2019 us-gaap Stock Issued1
StockIssued1
4500000
CY2020 mnkd Common Stock Issuance To Settle Employee Stock Purchase Plan Liability
CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability
684000
CY2019 mnkd Common Stock Issuance To Settle Employee Stock Purchase Plan Liability
CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability
656000
CY2020 mnkd Payment Of Interest On Senior Convertible Notes Through Common Stock Issuance
PaymentOfInterestOnSeniorConvertibleNotesThroughCommonStockIssuance
288000
CY2019 mnkd Payment Of Interest On Senior Convertible Notes Through Common Stock Issuance
PaymentOfInterestOnSeniorConvertibleNotesThroughCommonStockIssuance
1075000
CY2020 mnkd Issuance Of Warrants Associated With Credit Facility
IssuanceOfWarrantsAssociatedWithCreditFacility
275000
CY2019 mnkd Issuance Of Warrants Associated With Credit Facility
IssuanceOfWarrantsAssociatedWithCreditFacility
1854000
CY2020 mnkd Non Cash Receivable From At The Market Offering
NonCashReceivableFromAtTheMarketOffering
226000
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
92000
CY2019 mnkd Addition Of Right Of Use Assets
AdditionOfRightOfUseAssets
5192000
CY2019 mnkd Payment Of Facility Obligation Through Common Stock Issuance
PaymentOfFacilityObligationThroughCommonStockIssuance
4575000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3000000000.0
CY2020Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
122900000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67000000.0
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
40847000
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
47565000
CY2020 mnkd Contract With Customer Liability Upfront And Milestone Payments
ContractWithCustomerLiabilityUpfrontAndMilestonePayments
25000000
CY2019 mnkd Contract With Customer Liability Upfront And Milestone Payments
ContractWithCustomerLiabilityUpfrontAndMilestonePayments
25000000
CY2020 mnkd Contract With Customer Liability Pass Through Payments
ContractWithCustomerLiabilityPassThroughPayments
1910000
CY2019 mnkd Contract With Customer Liability Pass Through Payments
ContractWithCustomerLiabilityPassThroughPayments
6016000
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
32820000
CY2019 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
37734000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
34937000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
40847000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
158000
CY2019Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
316000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67005000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29906000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
67163000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30222000
CY2020Q4 mnkd Reserve For Returns
ReserveForReturns
2667000
CY2019Q4 mnkd Reserve For Returns
ReserveForReturns
1645000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4218000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
0
CY2019Q4 us-gaap Short Term Investments
ShortTermInvestments
20000000.0
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentration of Credit Risk<span style="font-style:normal;"> — Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents and short-term investments. Cash and cash equivalents are held in high credit quality institutions. Cash equivalents consist of interest-bearing money market accounts and U.S. Treasury securities, which are regularly monitored by management.</span>
CY2020Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
8090000
CY2019Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
6925000
CY2020Q4 mnkd Wholesaler Distribution Fees And Prompt Pay Discounts
WholesalerDistributionFeesAndPromptPayDiscounts
1205000
CY2019Q4 mnkd Wholesaler Distribution Fees And Prompt Pay Discounts
WholesalerDistributionFeesAndPromptPayDiscounts
1767000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3513000
CY2020 mnkd Number Of Wholesale Distributors
NumberOfWholesaleDistributors
3
CY2019 mnkd Number Of Wholesale Distributors
NumberOfWholesaleDistributors
3
CY2020 mnkd Percentage Of Sales From Major Customers
PercentageOfSalesFromMajorCustomers
0.86
CY2019 mnkd Percentage Of Sales From Major Customers
PercentageOfSalesFromMajorCustomers
0.96
CY2020Q4 mnkd Percentage Of Accounts Receivable From Major Customers
PercentageOfAccountsReceivableFromMajorCustomers
0.90
CY2019Q4 mnkd Percentage Of Accounts Receivable From Major Customers
PercentageOfAccountsReceivableFromMajorCustomers
0.94
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
600000
CY2019 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1751000
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2484000
CY2020Q4 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
3574000
CY2020Q4 us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
9250000
CY2020Q4 us-gaap Payments For Merger Related Costs
PaymentsForMergerRelatedCosts
531000
CY2020Q4 mnkd Business Acquisition Repayment Of Debt
BusinessAcquisitionRepaymentOfDebt
11000
CY2020Q4 us-gaap Business Combination Consideration Transferred Liabilities Incurred
BusinessCombinationConsiderationTransferredLiabilitiesIncurred
22000
CY2020Q4 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
155000
CY2020Q4 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
13233000
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1432000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1096000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
972000
CY2020Q4 us-gaap Inventory Net
InventoryNet
4973000
CY2019Q4 us-gaap Inventory Net
InventoryNet
4155000
CY2020 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
500000
CY2019 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
0
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
122687000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
122142000
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1393000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
96820000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25867000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26778000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
242117089
CY2020Q4 mnkd Deferred Social Security Taxes Cares Act
DeferredSocialSecurityTaxesCARESAct
1000000.0
CY2020 us-gaap Depreciation
Depreciation
1800000
CY2019 us-gaap Depreciation
Depreciation
1600000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11250000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8835000
CY2020Q4 mnkd Customer Discounts And Allowances
CustomerDiscountsAndAllowances
3688000
CY2019Q4 mnkd Customer Discounts And Allowances
CustomerDiscountsAndAllowances
3162000
CY2020Q4 us-gaap Direct Financing Lease Deferred Selling Profit
DirectFinancingLeaseDeferredSellingProfit
1422000
CY2019Q4 us-gaap Direct Financing Lease Deferred Selling Profit
DirectFinancingLeaseDeferredSellingProfit
1433000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
533000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
620000
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
409000
CY2020Q4 mnkd Sales And Marketing Related Expenses Accrued
SalesAndMarketingRelatedExpensesAccrued
99000
CY2019Q4 mnkd Sales And Marketing Related Expenses Accrued
SalesAndMarketingRelatedExpensesAccrued
147000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
859000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1298000
CY2020Q4 mnkd Current Portion Of Milestone Right Liability
CurrentPortionOfMilestoneRightLiability
1337000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19707000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15904000
CY2020Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
63027000
CY2019Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
70020000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
122235000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
118899000
CY2019Q4 mnkd Milestone Rights Liabilities Current And Noncurrent
MilestoneRightsLiabilitiesCurrentAndNoncurrent
7300000
CY2020 mnkd Payment For Milestone Rights Liabilities
PaymentForMilestoneRightsLiabilities
5000000.0
CY2020Q4 mnkd Milestone Rights Liabilities Current
MilestoneRightsLiabilitiesCurrent
1300000
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
4061000
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
9145000
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
25000000
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
84718000
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
122924000
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
665000
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
24000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
122235000
CY2019Q3 mnkd Early Termination Fees Percentage
EarlyTerminationFeesPercentage
0.0200
CY2019 mnkd Amortization Of Debt Premium
AmortizationOfDebtPremium
-1049000
CY2020 mnkd Amortization Of Debt Discount
AmortizationOfDebtDiscount
268000
CY2019 mnkd Amortization Of Debt Discount
AmortizationOfDebtDiscount
295000
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-101000
CY2019 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-111000
CY2020Q4 mnkd Milestone Rights Liabilities Current And Noncurrent
MilestoneRightsLiabilitiesCurrentAndNoncurrent
7300000
CY2020Q4 mnkd Milestone Rights Liabilities Noncurrent
MilestoneRightsLiabilitiesNoncurrent
5900000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
0
CY2020 mnkd Fair Value Of Debt Instruments To Related Party Description
FairValueOfDebtInstrumentsToRelatedPartyDescription
The fair value measurement of debt instruments is based on a discounted cash flow model and is sensitive to the change in yield (Level 3 in the fair value hierarchy
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
165800000
CY2019Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
110600000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
242117089
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
211787573
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
211787573
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-57240000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-51903000
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
222585000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
195584000
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
39682839
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12264616
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
6037542
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
7717480
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6511000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6203000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
1100000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
500000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
100000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
182000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
196400
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.30
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
432166
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.40
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1451403
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.55
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
183896
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
9.86
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12264616
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.41
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
15414000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
7493851
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.56
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
8079000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
970000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1320000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1057047
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.16
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
7009997
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.08
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1731076
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
1.81
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
298426
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
1.39
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
4500000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
3400000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
6037542
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.20
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
2500000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14135681
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.09
CY2020Q4 mnkd Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options In Period Grant Date Fair Value Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding
13300000
CY2019Q4 mnkd Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options In Period Grant Date Fair Value Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding
2300000
CY2019Q3 mnkd Purchase Obligation Extended Term
PurchaseObligationExtendedTerm
2026
CY2020Q4 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
9100000
CY2020Q4 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
8500000
CY2020Q4 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
10900000
CY2020Q4 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
14600000
CY2020Q4 us-gaap Purchase Obligation Due In Fifth Year
PurchaseObligationDueInFifthYear
15500000
CY2020Q4 mnkd Purchase Obligation Due In Sixth Year
PurchaseObligationDueInSixthYear
19400000
CY2020 mnkd Long Term Purchase Commitment Expiration Date
LongTermPurchaseCommitmentExpirationDate
2026-12-31
CY2020 mnkd Longterm Purchase Commitment Renewal Time Period
LongtermPurchaseCommitmentRenewalTimePeriod
P2Y
CY2020 mnkd Foreign Currency Hedging Transaction Period
ForeignCurrencyHedgingTransactionPeriod
P90D
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
1400000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
1800000
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
400000
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.075
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y10M24D
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
1500000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
1800000
CY2019 us-gaap Variable Lease Cost
VariableLeaseCost
400000
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.075
CY2020 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2019 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.75
CY2020 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
900000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
79455000
CY2019 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
1500000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-57458000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-51044000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-859000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-57458000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-51903000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-220000
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-218000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-218000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-4377000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-8551000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-469000
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
3299000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4846000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5252000
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-4846000
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-5252000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-218000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
533448000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
531970000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
80488000
CY2019Q4 mnkd Deferred Tax Assets Capitalized Research Expenses
DeferredTaxAssetsCapitalizedResearchExpenses
44000
CY2020Q4 mnkd Deferred Tax Assets Milestone Rights
DeferredTaxAssetsMilestoneRights
1547000
CY2019Q4 mnkd Deferred Tax Assets Milestone Rights
DeferredTaxAssetsMilestoneRights
1528000
CY2020Q4 mnkd Deferred Tax Assets Tax Deferred Expense Accrual Adjustment
DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment
1436000
CY2019Q4 mnkd Deferred Tax Assets Tax Deferred Expense Accrual Adjustment
DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment
1951000
CY2020Q4 mnkd Deferred Tax Assets Loss On Purchase Commitment
DeferredTaxAssetsLossOnPurchaseCommitment
23864000
CY2019Q4 mnkd Deferred Tax Assets Loss On Purchase Commitment
DeferredTaxAssetsLossOnPurchaseCommitment
22167000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3766000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3128000
CY2020Q4 mnkd Deferred Tax Assets Capitalized Costs
DeferredTaxAssetsCapitalizedCosts
5273000
CY2019Q4 mnkd Deferred Tax Assets Capitalized Costs
DeferredTaxAssetsCapitalizedCosts
4964000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
2093000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
147000
CY2020Q4 mnkd Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
559000
CY2019Q4 mnkd Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
827000
CY2020Q4 mnkd Deferred Tax Assets Interest Expense Limitation
DeferredTaxAssetsInterestExpenseLimitation
2460000
CY2019Q4 mnkd Deferred Tax Assets Interest Expense Limitation
DeferredTaxAssetsInterestExpenseLimitation
1167000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
20735000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
21132000
CY2020Q4 mnkd Deferred Tax Assets Product Revenue And Costs
DeferredTaxAssetsProductRevenueAndCosts
1569000
CY2019Q4 mnkd Deferred Tax Assets Product Revenue And Costs
DeferredTaxAssetsProductRevenueAndCosts
2062000
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.009
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
671575000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
675463000
CY2020 mnkd Effective Income Tax Rate Reconciliation Expirations Of Attribute
EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute
-0.066
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
670617000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
676205000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
742000
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
958000
CY2020Q4 mnkd Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
510000
CY2019Q4 mnkd Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
751000
CY2020Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
232000
CY2019Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
207000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
742000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
958000
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 mnkd Effective Income Tax Rate Reconciliation Permanent Items
EffectiveIncomeTaxRateReconciliationPermanentItems
-0.061
CY2019 mnkd Effective Income Tax Rate Reconciliation Permanent Items
EffectiveIncomeTaxRateReconciliationPermanentItems
-0.033
CY2019 mnkd Effective Income Tax Rate Reconciliation Effect Of Tax Law Changes
EffectiveIncomeTaxRateReconciliationEffectOfTaxLawChanges
-0.027
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.005
CY2019 mnkd Effective Income Tax Rate Reconciliation Expirations Of Attribute
EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute
-0.040
CY2020 mnkd Effective Income Tax Rate Reconciliation Foreign Withholding Tax
EffectiveIncomeTaxRateReconciliationForeignWithholdingTax
0.004
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.078
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.101
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.004
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
675500000
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-4800000
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-5300000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
2400000000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1300000000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
395200000
CY2020 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
Pursuant to Internal Revenue Code (“IRC”) Sections 382 and 383, annual use of the Company’s federal and state net operating loss and research and development credit carryforwards may be limited in the event a cumulative change in ownership of more than 50% occurs within a three-year period.
CY2004Q3 mnkd Operating Loss Carryforwards Subject To Limitation
OperatingLossCarryforwardsSubjectToLimitation
216000000.0
CY2004Q3 mnkd Net Operating Loss Carryforward Annual Limitation
NetOperatingLossCarryforwardAnnualLimitation
13000000.0
CY2020 mnkd Research And Development Credits Begin To Expire
ResearchAndDevelopmentCreditsBeginToExpire
2020
CY2020Q4 mnkd Deferred Tax Assets Tax Credit Carryforwards Research Expire
DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire
1000000.0
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
268902000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
268902000
CY2020Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
0
CY2020Q1 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
2000000000000

Files In Submission

Name View Source Status
0001564590-21-008440-index-headers.html Edgar Link pending
0001564590-21-008440-index.html Edgar Link pending
0001564590-21-008440.txt Edgar Link pending
0001564590-21-008440-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g0v4pdfglucx000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
mnkd-10k_20201231.htm Edgar Link pending
mnkd-10k_20201231_htm.xml Edgar Link completed
mnkd-20201231.xsd Edgar Link pending
mnkd-20201231_cal.xml Edgar Link unprocessable
mnkd-20201231_def.xml Edgar Link unprocessable
mnkd-20201231_lab.xml Edgar Link unprocessable
mnkd-20201231_pre.xml Edgar Link unprocessable
mnkd-ex1023_161.htm Edgar Link pending
mnkd-ex104_262.htm Edgar Link pending
mnkd-ex105_263.htm Edgar Link pending
mnkd-ex231_7.htm Edgar Link pending
mnkd-ex311_9.htm Edgar Link pending
mnkd-ex312_8.htm Edgar Link pending
mnkd-ex321_6.htm Edgar Link pending
mnkd-ex322_11.htm Edgar Link pending
mnkd-ex43_10.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending